Media

* Individual results may vary.

Logo – Contract Pharma

RenovoRx, Imugene Partner to Deliver Oncolytic Virus Therapy

RenovoRx, Inc., a clinical-stage biopharmaceutical company developing targeted combination therapies, and Imugene Ltd., a clinical-stage immuno-oncology company, entered into a strategic research collaboration to optimize the delivery of Imugene’s oncolytic virus…